The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Recurrence, Local; Indenes; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Chemotherapy, Adjuvant; Nephrectomy; Administration, Oral; Infusions, Intravenous; Double-Blind Method
PubMed ID
42384869
Added to directory
Source checked

Report a correction or request removal